Skip to main content
Caralee Forseen, MD, Pulmonology, Augusta, GA

CaraleeJ.ForseenMD

Pulmonology Augusta, GA

Asthma & COPD, Critical Care Medicine, Cystic Fibrosis

Associate Professor, Medicine, Medical College of Georgia at Augusta University

Dr. Forseen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Forseen's full profile

Already have an account?

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
  • University of North Dakota
    University of North DakotaResidency, Internal Medicine, 1998 - 2001
  • University of North Dakota School of Medicine and Health Sciences
    University of North Dakota School of Medicine and Health SciencesClass of 1998

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2005 - 2025
  • TX State Medical License
    TX State Medical License 2004 - 2016
  • AZ State Medical License
    AZ State Medical License 2008 - 2009
  • ND State Medical License
    ND State Medical License 2000 - 2002
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Exercise Testing in Patients with Cystic Fibrosis—Importance of Ventilatory Parameters  
    Caralee Forseen, Kathleen T McKie, European Journal of Applied Physiology

Press Mentions

  • Study at MCG Aiming to Improve Quality and Span of Life for Cystic Fibrosis Patients
    Study at MCG Aiming to Improve Quality and Span of Life for Cystic Fibrosis PatientsApril 2nd, 2021
  • New Drug Gives Hope to Cystric Fibrosis Patients
    New Drug Gives Hope to Cystric Fibrosis PatientsMarch 2nd, 2019